Results 121 to 130 of about 859,888 (229)

Inequities in Access to Tricuspid Valve Treatments

JACC: Advances
Background: Opportunities to minimize inequities in accessing treatments for tricuspid regurgitation disease should be considered. Objective: The objective of this study was to explore how access to new tricuspid regurgitation technologies change when ...
Colin M. Barker, MD, Lisa S. Kemp, PhD, Melissa Mancilla, MBA, Sarah Mollenkopf, MPH, Candace Gunnarsson, PhD, Michael Ryan, MS, Guy David, PhD   +6 more
doaj   +1 more source

Nine‐Year Follow‐Up After M‐TEER for Secondary Mitral Regurgitation in a Patient With Cardiogenic Shock

Catheterization and Cardiovascular Interventions, Volume 108, Issue 2, Page 483-488, August 1, 2026.
ABSTRACT Background Transcatheter edge‐to‐edge repair (TEER) has become an established therapeutic option for patients with severe secondary mitral regurgitation (SMR). While randomized trials and registry data have reported outcomes up to 5 years, longer follow‐up data remain scarce.
Tobias Reithmayer, Thomas J. Stocker, Ludwig T. Weckbach, Julia Novotny, Philipp M. Doldi, Hannah Kempton, Steffen Massberg, Michael Näbauer, Jörg Hausleiter, Lukas Stolz   +9 more
wiley   +1 more source

Video_5_Case report: Transcatheter edge-to-edge repair after prior surgical tricuspid annuloplasty.MP4

, 2022
Residual and recurrent tricuspid regurgitation may occur frequently after surgical tricuspid valve repair. However, reoperation for tricuspid regurgitation is rare, although many patients are again highly symptomatic. Tricuspid transcatheter edge-to-edge
Jafer Haschemi (14023287), Shazia Afzal (4739562), Patrick Horn (47116), Malte Kelm (45981), Florian Bönner (326503)   +4 more
core   +1 more source

Concomitant transcatheter edge-to-edge treatment for mitral regurgitation and the K-Clip system for tricuspid regurgitation: one case report

Frontiers in Cardiovascular Medicine
Transcatheter valve repair is an important alternative therapy for patients with severe valvular regurgitation who are at high risk for or contraindicated to undergo surgical procedures.
Cai He, Hui Guo, Wenwen Chen, Wei Wang
doaj   +1 more source

The “Spider and the Fly” Technique for Transcatheter Tricuspid Valve Replacement in Failed Edge-to-Edge Repair

JACC Case Reports
Background Failed tricuspid edge-to-edge repair with recurrent symptoms poses a challenge for optimal management. We report the first case successfully treated with transcatheter tricuspid valve replacement using the EVOQUE system after transcatheter ...
M. Gennari, C. Ferrari, F. Fazzari, F. de Marco   +3 more
semanticscholar   +1 more source

Impella‐Assisted High‐Risk Percutaneous Coronary Intervention in Cardiogenic Shock With Low‐Flow, Low‐Gradient Aortic Stenosis and Multivessel Coronary Artery Disease: A Case Report

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Patients with cardiogenic shock, low‐flow, low‐gradient aortic stenosis, and multivessel coronary artery disease who are ineligible for surgery present a major therapeutic challenge. Percutaneous mechanical circulatory support may facilitate revascularization in this high‐risk population. A 69‐year‐old man presented after a mechanical fall and
Douni Roger, Waleed Shaker, Zan Siddiqi, George Abela   +3 more
wiley   +1 more source

Effects of tricuspid transcatheter edge-to-edge repair on tricuspid annulus diameter - Data from the TriValve registry. [PDF]

AIMS T-TEER is an effective therapy for the treatment of tricuspid regurgitation (TR). However, the effects of leaflets clipping on tricuspid valve annulus (TA) have not been investigated in detail.
Maisano, Francesco, Sievert, Horst, Hahn, Rebecca T, Webb, John, Alessandrini, Hannes, Rommel, Karl-Philipp, Russo, Giulio, Gavazzoni, Mara, Badano, Luigi P, Thiele, Holger, von Bardeleben, Ralph Stephan, Tang, Gilbert, Himbert, Dominique, Nickenig, Georg, Rodes-Cabau, Joseph, Schofer, Joachim, Ludwig, Sebastian, Windecker, Stephan, Latib, Azeem, Leon, Martin, Pozzoli, Alberto, Praz, Fabien, Connelly, Kim A, Pedicino, Daniela, Fam, Neil, Andreas, Martin, Braun, Daniel, Lubos, Edith, Pedrazzini, Giovanni, Denti, Paolo, Lurz, Philipp, Unterhuber, Matthias, Estevez-Loureiro, Rodrigo, Hausleiter, Joerg, Monivas, Vanessa, Kalbacher, Daniel, Taramasso, Maurizio, von Bardeleben R. S., Praz F., Russo G., Sievert H., Maisano F., Lubos E., Alessandrini H., Kalbacher D., Pedicino D., Monivas V., Rommel K. -P., Himbert D., Latib A., Andreas M., Ludwig S., Taramasso M., Gavazzoni M., Braun D., Lurz P., Pedrazzini G., Pozzoli A., Rodes-Cabau J., Connelly K. A., Unterhuber M., Badano L. P., Leon M., Thiele H., Hahn R. T., Schofer J., Tang G., Denti P., Fam N., Estevez-Loureiro R., Windecker S., Hausleiter J., Nickenig G., Webb J.   +73 more
core   +1 more source

Video_1_Case report: Transcatheter edge-to-edge repair after prior surgical tricuspid annuloplasty.MP4

, 2022
Residual and recurrent tricuspid regurgitation may occur frequently after surgical tricuspid valve repair. However, reoperation for tricuspid regurgitation is rare, although many patients are again highly symptomatic. Tricuspid transcatheter edge-to-edge
Jafer Haschemi (14023287), Shazia Afzal (4739562), Patrick Horn (47116), Malte Kelm (45981), Florian Bönner (326503)   +4 more
core   +1 more source

Transcatheter Repair of Tricuspid Valve Regurgitation: A Systematic Review

Journal of Clinical Medicine
Introduction: Clinically significant severe tricuspid regurgitation (TR) is a common untreated pathology associated with increased mortality. Even though surgical valve replacement has been the mainstay option, transcatheter intervention is a novel and potentially effective tool.
Aswin Srinivasan, Jonathan Brown, Alexander Rhodes, Sobia Khan, Viswanath Chinta, Pranav Loyalka, Arnav Kumar   +6 more
openaire   +2 more sources

Transcatheter Tricuspid Valve Edge-to-Edge Repair in Cardiac Wild-Type Transthyretin Amyloidosis

JACC Case Reports
Background Cardiac transthyretin amyloidosis (ATTR-CM) is an infiltrative, restrictive cardiomyopathy leading to heart failure across all stages of the disease.
S. Schwarting, L. Stolz, Julia Novotny, S. Massberg, M. Nabauer, J. Hausleiter   +5 more
semanticscholar   +1 more source